Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 12 articles: HTML format Text format

Single Articles

May 2018
1. CHEN EY, Blanke CD, Haller DG, Benson AB, et al
   A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer.
   Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000465.
   PubMed     Text format     Abstract available
   
   
   April 2018
2. BATES JE, Choi G, Usuki KY, Katz AW, et al
   Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy.
   Am J Clin Oncol. 2018 Apr 16. doi: 10.1097/COC.0000000000000445.
   PubMed     Text format     Abstract available
   
   
   January 2018
3. LAURENT M, Des Guetz G, Bastuji-Garin S, Culine S, et al
   Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6.
   Am J Clin Oncol. 2018;41:73-80.
   PubMed     Text format     Abstract available
   
   
   
4. SHANKARAN V, Ortendahl JD, Purdum AG, Bolinder B, et al
   Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States.
   Am J Clin Oncol. 2018;41:65-72.
   PubMed     Text format     Abstract available
   
   
   
5. QIU H, Katz AW, Chowdhry AK, Usuki KY, et al
   Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
   Am J Clin Oncol. 2018;41:53-58.
   PubMed     Text format     Abstract available
   
   
   December 2017
6. CHABLANI P, Nguyen P, Pan X, Robinson A, et al
   Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery.
   Am J Clin Oncol. 2017;40:561-568.
   PubMed     Text format     Abstract available
   
   
   
7. VOONG KR, Rashid A, Crane CH, Minsky BD, et al
   Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
   Am J Clin Oncol. 2017;40:555-560.
   PubMed     Text format     Abstract available
   
   
   
8. OSTI MF, Nicosia L, Agolli L, Gentile G, et al
   Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy.
   Am J Clin Oncol. 2017;40:535-542.
   PubMed     Text format     Abstract available
   
   
   
9. AHN DH, Wu C, Wei L, Williams TM, et al
   The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.
   Am J Clin Oncol. 2017;40:531-534.
   PubMed     Text format     Abstract available
   
   
   October 2017
10. YEOP OH S, Bae Kim Y, Wook Suh K
    Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer.
    Am J Clin Oncol. 2017;40:512-516.
    PubMed     Text format     Abstract available
    
    
    
11. CHARLTON ME, Karlitz JJ, Schlichting JA, Chen VW, et al
    Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.
    Am J Clin Oncol. 2017;40:498-506.
    PubMed     Text format     Abstract available
    
    
    February 2016
12. CALL JA, Prendergast BM, Jensen LG, Ord CB, et al
    Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study.
    Am J Clin Oncol. 2016;39:8-12.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: